276 related articles for article (PubMed ID: 23213092)
1. Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.
Divgi CR; Uzzo RG; Gatsonis C; Bartz R; Treutner S; Yu JQ; Chen D; Carrasquillo JA; Larson S; Bevan P; Russo P
J Clin Oncol; 2013 Jan; 31(2):187-94. PubMed ID: 23213092
[TBL] [Abstract][Full Text] [Related]
2. Positron Emission Tomography/Computed Tomography with
Hekman MCH; Rijpkema M; Aarntzen EH; Mulder SF; Langenhuijsen JF; Oosterwijk E; Boerman OC; Oyen WJG; Mulders PFA
Eur Urol; 2018 Sep; 74(3):257-260. PubMed ID: 29730017
[TBL] [Abstract][Full Text] [Related]
3. Targeted PET/CT imaging for clear cell renal cell carcinoma with radiolabeled antibodies: recent developments using girentuximab.
van Oostenbrugge T; Mulders P
Curr Opin Urol; 2021 May; 31(3):249-254. PubMed ID: 33742975
[TBL] [Abstract][Full Text] [Related]
4. Lesion detection by [
Verhoeff SR; van Es SC; Boon E; van Helden E; Angus L; Elias SG; Oosting SF; Aarntzen EH; Brouwers AH; Kwee TC; Heskamp S; Hoekstra OS; Verheul H; van der Veldt AAM; de Vries EGE; Boerman OC; van der Graaf WTA; Oyen WJG; van Herpen CML
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1931-1939. PubMed ID: 31172212
[TBL] [Abstract][Full Text] [Related]
5. PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
Turkbey B; Lindenberg ML; Adler S; Kurdziel KA; McKinney YL; Weaver J; Vocke CD; Anver M; Bratslavsky G; Eclarinal P; Kwarteng G; Lin FI; Yaqub-Ogun N; Merino MJ; Linehan WM; Choyke PL; Metwalli AR
Abdom Radiol (NY); 2016 Jan; 41(1):109-18. PubMed ID: 26830617
[TBL] [Abstract][Full Text] [Related]
6. Re: positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.
Laguna MP
J Urol; 2013 Aug; 190(2):493. PubMed ID: 23845328
[No Abstract] [Full Text] [Related]
7. PET/CT with (124)I-cG250: great potential and some open questions.
Khandani AH; Rathmell WK; Wallen EM; Ivanovic M
AJR Am J Roentgenol; 2014 Aug; 203(2):261-2. PubMed ID: 25055257
[TBL] [Abstract][Full Text] [Related]
8. Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma.
Muselaers CH; Boerman OC; Oosterwijk E; Langenhuijsen JF; Oyen WJ; Mulders PF
Eur Urol; 2013 Jun; 63(6):1101-6. PubMed ID: 23453421
[TBL] [Abstract][Full Text] [Related]
9. Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.
Divgi CR; Pandit-Taskar N; Jungbluth AA; Reuter VE; Gönen M; Ruan S; Pierre C; Nagel A; Pryma DA; Humm J; Larson SM; Old LJ; Russo P
Lancet Oncol; 2007 Apr; 8(4):304-10. PubMed ID: 17395103
[TBL] [Abstract][Full Text] [Related]
10. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
11. Phase I study to assess safety, biodistribution and radiation dosimetry for
Merkx RIJ; Lobeek D; Konijnenberg M; Jiménez-Franco LD; Kluge A; Oosterwijk E; Mulders PFA; Rijpkema M
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3277-3285. PubMed ID: 33651116
[TBL] [Abstract][Full Text] [Related]
12. External Validation of a Five-Tiered CT Algorithm for the Diagnosis of Clear Cell Renal Cell Carcinoma: A Retrospective Five-Reader Study.
Lemieux S; Shen L; Liang T; Lo E; Chu Y; Kamaya A; Tse JR
AJR Am J Roentgenol; 2023 Sep; 221(3):334-343. PubMed ID: 37162037
[No Abstract] [Full Text] [Related]
13. (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma.
Demirci E; Ocak M; Kabasakal L; Decristoforo C; Talat Z; Halaç M; Kanmaz B
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1461-2. PubMed ID: 24756358
[No Abstract] [Full Text] [Related]
14. Multimodal imaging and detection strategy with 124 I-labeled chimeric monoclonal antibody cG250 for accurate localization and confirmation of extent of disease during laparoscopic and open surgical resection of clear cell renal cell carcinoma.
Povoski SP; Hall NC; Murrey DA; Sharp DS; Hitchcock CL; Mojzisik CM; Bahnson EE; Knopp MV; Martin EW; Bahnson RR
Surg Innov; 2013 Feb; 20(1):59-69. PubMed ID: 22455975
[TBL] [Abstract][Full Text] [Related]
15. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.
Rowe SP; Gorin MA; Hammers HJ; Som Javadi M; Hawasli H; Szabo Z; Cho SY; Pomper MG; Allaf ME
Ann Nucl Med; 2015 Dec; 29(10):877-82. PubMed ID: 26286635
[TBL] [Abstract][Full Text] [Related]
16. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
Namura K; Minamimoto R; Yao M; Makiyama K; Murakami T; Sano F; Hayashi N; Tateishi U; Ishigaki H; Kishida T; Miura T; Kobayashi K; Noguchi S; Inoue T; Kubota Y; Nakaigawa N
BMC Cancer; 2010 Dec; 10():667. PubMed ID: 21129184
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation.
Zhu H; Zhao S; Zuo C; Ren F
AJR Am J Roentgenol; 2020 Sep; 215(3):645-651. PubMed ID: 32755159
[No Abstract] [Full Text] [Related]
19. Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.
Fletcher JW; Logan TF; Eitel JA; Mathias CJ; Ng Y; Lacy JL; Hutchins GD; Green MA
J Nucl Med; 2015 Jan; 56(1):56-62. PubMed ID: 25525184
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study.
Hekman MC; Rijpkema M; Muselaers CH; Oosterwijk E; Hulsbergen-Van de Kaa CA; Boerman OC; Oyen WJ; Langenhuijsen JF; Mulders PF
Theranostics; 2018; 8(8):2161-2170. PubMed ID: 29721070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
